VERA THERAPEUTICS INC (VERA:NASDAQ)
$42 -0.45 (-1.0601%)
Analysed VERA THERAPEUTICS INC (VERA:NASDAQ) News Sources
Vera Therapeutics Shares Climb Ahead of FDA Decision on Atacicept (VERA)
06-07-2026
advfn.com
Vera Therapeutics wins FDA nod for closely watched kidney disease drug
07-07-2026
biopharmadive.com
Vera Therapeutics Receives FDA Accelerated Approval for TRUTAKNA™ for Adult Patients with Primary IgA Nephropathy
07-07-2026
yahoo.com
VERA Stock Surges After Drug To Treat Rare Kidney Disease Gets FDA Approval – Retail Sees The Move As Catalyst For Vera Therapeutics
07-07-2026
stocktwits.com
Sector Update: Healthcare Stocks Gain Late Afternoon
07-07-2026
yahoo.com
Vera Therapeutics Announces Appointment of Nancy Boman as Chief Regulatory Officer and Planned Retirement of William Turner
09-07-2026
yahoo.com
Vera Therapeutics (VERA) Stock Looks Fully Valued After Its 185% Run
10-07-2026
yahoo.com
Vera Therapeutics (VERA) Could Be 92% Below Fair Value After FDA Approval
10-07-2026
yahoo.com
Is FDA Accelerated Approval Of TRUTAKNA Transforming The Investment Case For Vera Therapeutics (VERA)?
10-07-2026
yahoo.com
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
10-07-2026
yahoo.com
What is the current price of VERA THERAPEUTICS INC (VERA:NASDAQ)?
The current price of VERA THERAPEUTICS INC (VERA:NASDAQ) is $42.
VERA THERAPEUTICS INC (VERA:NASDAQ) absolute price change since previous trading day?
The absolute price change of VERA THERAPEUTICS INC (VERA:NASDAQ) since the previous trading day is $-0.45.
VERA THERAPEUTICS INC (VERA:NASDAQ) percentage price change since previous trading day?
The percentage price change of VERA THERAPEUTICS INC (VERA:NASDAQ) since the previous trading day is -1.0601%.
What is the most recent average sentiment score for VERA THERAPEUTICS INC (VERA:NASDAQ)?
The most recent average sentiment score for VERA THERAPEUTICS INC (VERA:NASDAQ) is 87 out of 100.
What is the most recent average sentiment for VERA THERAPEUTICS INC (VERA:NASDAQ)?
The most recent sentiment for VERA THERAPEUTICS INC (VERA:NASDAQ) is .
SEC-8K** Filing Available For VERA THERAPEUTICS INC (VERA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.